Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05378620 · ClinicalTrials.gov registry record · NA
Project Dulce for Filipino-Americans With Type 2 Diabetes
A NA study, sponsored by Scripps Whittier Diabetes Institute.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT05378620 is a NA study that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 29 participants.
The verdict
NCT05378620, a NA study, has completed, sponsored by Scripps Whittier Diabetes Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barriers to DSMES unique to FAs, such as linguistic challenges, health literacy and numeracy, cultural beliefs and values, and technology access and use. In addition, this study aims to examine the effectiveness of the culturally and digitally adapted Project Dulce + Dulce Digital in improving diabetes knowledge, belief, attitudes, hemoglobin A1C (glycosylated hemoglobin), and self-management behaviors at baseline to 3 months and 6 months. The unprecedented increase of T2DM prevalence among racial and ethnic minority populations including FAs in recent decades demands for effective strategies to meet the needs in DSMES in this population. The outcomes of the current study will demonstrate that the culturally adapted Project Dulce and integration of Dulce Digital is effective in addressing the needs FAs, an underserved racial and ethnic minority group in high need of culturally appropriate DSMES.
Interventions
- BEHAVIORAL Project Dulce + Dulce Digital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2025-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05378620
The ClinicalTrials.gov registry entry for NCT05378620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Project Dulce + Dulce Digital is the first listed.
NCT05378620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05378620 about?
NCT05378620 is a clinical study titled "Project Dulce for Filipino-Americans With Type 2 Diabetes". This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation ...
What is the current status of trial NCT05378620?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2022-10-17. Estimated completion is 2025-12-12.
What interventions are being tested in trial NCT05378620?
The interventions under investigation include: Project Dulce + Dulce Digital (BEHAVIORAL).
Who is sponsoring clinical trial NCT05378620?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.